Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-01-30

FDA Approved: NORGESTIMATE AND ETHINYL ESTRADIOL — Original Application (AvKARE)

View source ↗

Summary

FDA approves AvKARE's generic oral contraceptive combination of norgestimate and ethinyl estradiol through an original ANDA submission.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NORGESTIMATE AND ETHINYL ESTRADIOL (norgestimate and ethinyl estradiol)

Snippet

ORIG AP for NORGESTIMATE AND ETHINYL ESTRADIOL (NORGESTIMATE AND ETHINYL ESTRADIOL)